Stabilization and Reduced Cytotoxicity of Amyloid Beta Aggregates in the Presence of Catechol Neurotransmitters
- 17 October 2023
- journal article
- research article
- Published by Springer Nature in Neurochemical Research
- Vol. 49 (2) , 379-387
Abstract
Oligomeric aggregates of the amyloid-beta (Aβ) peptide have been implicated as the toxic species for Alzheimer’s disease by contributing to oxidative cytotoxicity and physical disruption in cell membranes in the brain. Recent evidence points to the ability of the catecholamine neurotransmitter dopamine in the presence of copper ions to both stabilize oligomers and decrease the toxic effects of these oligomers. Based on these results, physical characterization of aggregates and subsequent cell studies with a neuroblastoma line were performed that show both dopamine and the related neurotransmitter, norepinephrine, can stabilize oligomers and decrease toxicity of Aβ aggregates without copper present. To investigate this reduction of toxicity, structural characterization of oligomers in the presence of neurotransmitters was compared to aggregates formed with Aβ alone. Gel electrophoresis and transmission electron microscopy show higher levels of oligomers in the presence of dopamine and norepinephrine, yet the oligomer structure is largely amorphous. Aβ aggregated alone forms the predicted highly organized fibrillar species, with increased levels of dityrosine covalent linkages, which are largely absent in the presence of the neurotransmitters. A proposed mechanism for the observed decrease in cell death by Aβ in the presence of dopamine and norepinephrine suggests the neurotransmitters both block the formation of organized oligomer structures and dityrosine stabilizing linkages while also behaving as antioxidants, providing a dual mechanism for increased cell viability.Keywords
Funding Information
- Undergraduate Research Program, Elon University
- Elon Honors Fellows
- J.E. Rawls Professorship
This publication has 40 references indexed in Scilit:
- A central role for dityrosine crosslinking of Amyloid-β in Alzheimer’s diseaseActa Neuropathologica Communications, 2013
- The Aβ oligomer hypothesis for synapse failure and memory loss in Alzheimer’s diseaseNeurobiology of Learning and Memory, 2011
- Catechol derivatives inhibit the fibril formation of amyloid-β peptidesJournal of Bioscience and Bioengineering, 2010
- Intracellular accumulation of amyloid-beta – a predictor for synaptic dysfunction and neuron loss in Alzheimer’s diseaseFrontiers in Aging Neuroscience, 2010
- Small Molecule Inhibitors of Aggregation Indicate That Amyloid β Oligomerization and Fibrillization Pathways Are Independent and DistinctJournal of Biological Chemistry, 2007
- Dityrosine as a product of oxidative stress and fluorescent probeAmino Acids, 2003
- Dityrosine Cross-Linked Aβ Peptides: Fibrillar β-Structure in Aβ(1-40) Is Conducive to Formation of Dityrosine Cross-Links but a Dityrosine Cross-Link in Aβ(8-14) Does Not Induce β-StructureChemical Research in Toxicology, 2003
- In vitro peroxidase oxidation induces stable dimers of β-amyloid (1-42) through dityrosine bridge formationAmyloid, 1999
- β-Amyloid-Associated Free Radical Oxidative Stress and Neurotoxicity: Implications for Alzheimer's DiseaseChemical Research in Toxicology, 1997
- Alzheimer's Disease: The Amyloid Cascade HypothesisScience, 1992